...potential capital crunch, then those valuations may become more attractive across the board,” he said. Sailing Capital’s...

...important topic because it has implications on a lot of newer technologies being developed,” said Sailing Capital’s...
...“How do we make this work when people are charging $1 million plus?” Bosun Hau, Sailing Capital...

...time, learn the landscape, I think there’s less competition in Europe,” said Bosun Hau of Sailing Capital...
...at €345 million ($428 million). “I think the Chinese valuations are just astronomical.” Bosun Hau, Sailing Capital...
...global development and access to the Chinese market long-term. For instance, Hau noted that because Sailing Capital’s...

...San Diego, Calif. Business: Endocrine/Metabolic Date completed: 2015-10-01 Type: Venture financing Raised: $20 million Investors: Sailing Capital...

...in the first tranche of a $40 million series E round led by new investor Sailing Capital...
...IIb trial of Metformin DR, a delayed-release formulation of metformin, to treat Type II diabetes. Sailing Capital's...